Human Embryonic Stem Cell Derived Dopaminergic Cells（Skane Region）

N/A

Report date: 2023/01/12 16:08:20

Base Information

Drug NameHuman Embryonic Stem Cell Derived Dopaminergic Cells（Skane Region）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSkane Region CouncilUniversity Of CambridgeLund University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CambridgeSkane Region CouncilLund University
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A